Menu
Contact Us
Search
GO
Why Choose Us
Innovative Approaches
Conditions
Centers & Programs
For Families
For Physicians
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
Why Choose Us
Expertise
Survivorship
Global Health
Leadership
History and Milestones
Innovative Approaches
CAR T-Cell Therapy
Clinical Trials for Relapsed Cancer
Gene Therapy
Immunotherapy for Children
MIBG Therapy
Pediatric Cancer Genetic Risk Program
Precision Medicine
Stem Cell Transplant
Conditions
Blood Disorders
Brain Tumors
Leukemia, Lymphoma, and Histiocytosis
Solid Tumors
Other Conditions We Treat
Centers & Programs
Blood Disorders Center
Brain Tumor Center
Hematologic Malignancy Center
Solid Tumor Center
For Families
Become a Patient
Insurance and Financial Information
Our Facilities
Patient & Family Advisory Council
Patient and Family Support Services
Five Things Parents Should Know
Childhood Cancer Awareness Month
Education Resources
For Physicians
Referrals and Second Opinions
Clinical Trials & Research
Research Labs
Fellowship Overview
Affiliations and Consortia
Continuing Medical Education
Newsletter Sign Up
Home
>
News
Share
Print
Print
News
Sorted by:
Date
|
Title
Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries
December 19, 2018
The research will focus on adapting gene therapy for use in low-resource areas with high rates of the disease.
New gene therapy strategy for sickle cell disease shows early promise in humans
December 01, 2018
A patient with a severe form of sickle cell disease is symptom-free after gene therapy knocks down BCL11A and restores fetal hemoglobin production.
A new gene therapy transplantation technique could improve treatment of neurodegenerative disease
December 06, 2017
Alessandra Biffi, MD, led a study that shows the efficacy of a new gene therapy transplantation technique that could have future applications for treating neurodegenerative diseases.
New gene therapy clinical trial offers hope for sickle cell disease
November 14, 2017
David Williams, MD, discusses Dana-Farber/Boston Children's new gene therapy clinical trial for sickle cell disease in a live webchat.
Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial
October 04, 2017
The devastating neurodegenerative disease typically affects young boys and causes death within 10 years
The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial
October 04, 2017
For the Rojas family, a clinical trial of gene therapy for adrenoleukodystrophy has meant both happiness and heartache.
Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome
August 23, 2017
After being diagnosed with Wiskott-Aldrich syndrome, Duy Anh "Harry" Le traveled with his family to Boston for a gene therapy clinical trial, and is now a happy and healthy two-year-old.
Gene Therapy 2.0
March 15, 2017
Levi Looks, diagnosed through newborn screening with “bubble boy” disease, is a healthy toddler thanks to gene therapy, resurgent now after early setbacks, MIT Technology Review reports.
One boy’s cure raises hopes and questions about gene therapy for sickle cell disease
March 01, 2017
Dana-Farber/Boston Children’s researchers, who are developing a gene therapy trial for sickle cell disease, commented in Stat and other outlets on a case report from a different trial.
Gene therapy trial gives Coopersville toddler second chance at life
December 07, 2016
A West Michigan toddler born with “bubble boy” disease is active and healthy, thanks to newborn screening and gene therapy, Fox 17 TV in Grand Rapids reports.
Showing 1-10 of 30 items
Next